Company page

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (ticker: NBIX) is a public company based in the United States, specializing in the development of treatments for neurological and endocrine diseases. With a market capitalization of approximately $16.06 billion, the company is focused on advancing innovative therapies to improve patient outcomes.